|
General Information
|
|
|
Product
|
Phospho-Androgen Receptor Antibody
|
|
Verified Applications
|
ELISA, IP, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Human, Mouse, Rat
|
|
Immunogen
|
Synthetic peptide corresponding to amino acids within region 550-600 on Human Androgen Receptor. Phospho Serine 568.
|
|
Physical Properties
|
|
|
Quantity
|
100 ug
|
|
Concentration
|
0.5-1.5 μg/μl in antibody stabilization buffer
|
|
Immunoglobulin
|
IgG
|
|
Conjugate
|
Unconjugated
|
|
Purification Method
|
Immobilized antigen affinity chromatography
|
|
Clonality
|
Polyclonal
|
|
Modification
|
Phosphorylated
|
|
Storage
|
-20°C for long term storage
|
|
Application Protocol
|
|
ELISA
|
1:10,000
|
|
Immunoprecipitation
|
1:200
|
|
Western Blot
|
1:500
|
|
Protein
|
|
Uniprot #
|
P10275
|
|
Subcellular Location
|
Cytoplasm, Nucleus
|
|
Expression
|
Isoform 2:
Mainly expressed in heart and skeletal muscle.=
Isoform 3:
Expressed in basal and stromal cells of the prostate (at protein level).
|
|
Structure
|
Belongs to the nuclear hormone receptor family. NR3 subfamily.
|
|
Alternative Nomenclature
|
AIS
ANDR_HUMAN
Androgen nuclear receptor variant 2
Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)
Androgen receptor
androgen receptor splice variant 4b
AR
AR8
DHTR
Dihydrotestosterone receptor
HUMARA
HYSP1
KD
Kennedy disease (KD)
NR3C4
Nuclear receptor subfamily 3 group C member 4 (NR3C4)
SBMA
SMAX1
Spinal and bulbar muscular atrophy (SBMA)
Testicular Feminization (TFM)
TFM
|
| |
|
Phospho-Androgen Receptor Antibody BIOTIN
Phospho-Androgen Receptor Antibody FITC
Phospho-Androgen Receptor Blocking Peptide
Phospho-Androgen Receptor Positive Control
